Navigating the treatment paradigms for atopic dermatitis
Atopic dermatitis (AD) symptoms fluctuate between stable disease and acute flare-ups. The step-up guidelines to better manage acute flare-ups, and worsening disease severity, include topical therapies for mild-to-moderate AD and systemic therapies for moderate-severe AD. Choosing different therapies is only one potential factor to improve patient outcomes. Non-adherence to treatment also limits patient outcomes for a variety of reasons, including lack of trust/understanding about disease management, inconvenience, and fear of side effects, among others.
Given an increasing range of therapeutic options for moderate AD, which include novel topical therapies, it may be useful to revisit the step-up paradigm.
- What are the key factors to consider for mild-to-moderate AD treatment choices after disease flare-ups?
- For moderate AD patients, when is a transition to additional/newer topical treatments preferable to oral therapies?
If not improving with moderate to severe AD, then I will consider systemics/bologics/oral JAKs.
Oral antihistamine regardless to help control the itch. I try to limit oral steroids as much as possible. Sometimes use increase potency topical steroids, if insurance will cover then elidel or eucrisa. It's ridiculously hard here to get eucrisa approved.
Baseline hydration is always the most important. If they're not improving, we get a Derm referral
For moderate AD patients, any of the newer topical agents can be tried, but I'd reserve the oral JAK inhibitors for only the most severe patients, given their multiple black box warnings. Dupixent is generally preferred by patients as the first systemic option (beyond oral antihistamines). And allergen immunotherapy remains an effective modulatory treatment for many allergic AD patients, although some patients may flare a bit during the initial build-up phase.
At St. John's in London we used wraps on top of a bland emollient base with weak additions of hydrocortisone. I prefer Aveeno cream and hydrocortisone ointment.
If not improving with moderate to severe AD, then I will consider systemics/bologics/oral JAKs.
I generally advise pts to consider maintenance therapy (topical non steroid options like the calcineurin inhibitors and Eucrisa ) and topical steroids and now opzelura for flares
Individual cases differ as to what else is needed (eg systemic antihistamines etc)
We also discuss lifestyle and environmental triggers